Martin Stumpe Appointed as Chief Technology and AI Officer at Danaher
Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Martin Stumpe will be appointed Chief Technology and AI Officer,
As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Martin Stumpe will be appointed Chief Technology and AI Officer,
Greg Milosevich joined Danaher in 2010, through the acquisition of Molecular Devices, and since has held roles of increasing responsibility across multiple businesses.
“Deborah Andrews has blended seamlessly with the leadership team, and we quickly realized that her deep knowledge of STAAR and her skills, abilities, and approach made her the perfect choice to be STAAR’s next CFO,” said the Company’s CEO and Board member, Stephen Farrell.
In this role, Greg Kraus will lead project and operational excellence initiatives across Allient sites contributing to defense market solutions, while also serving as General Manager of Allient’s Watertown, NY facility.
Chris Locke brings over two decades of global experience in medical device R&D, technology strategy, and organisational transformation.
Dr. Beddingfield is a 22-year veteran of the biopharma industry